linked in

Somerset, New Jersey, January 24, 2007

SommaTech Consulting, helping clients achieve their FDA regulated product goals for a fast submission and seamless approval, today announced a strategic collaboration with Pharmaceutical Technologies International, Inc. (PTI Inc.), a developer of state-of-the-art tablet formulation expert systems and compaction simulation technology...

Sommatech Consulting Announces Strategic Collaboration With Pharmaceutical Technologies, Inc.
--Compaction simulation accelerates tablet development and scale-up for pharmaceutical clients--

Somerset, New Jersey, January 24, 2007

SommaTech Consulting, helping clients achieve their FDA regulated product goals for a fast submission and seamless approval, today announced a strategic collaboration with Pharmaceutical Technologies International, Inc. (PTI Inc.), a developer of state-of-the-art tablet formulation expert systems and compaction simulation technology. Compaction Simulation enables formulators to analyze and characterize the tabletability properties of new active pharmaceutical ingredients (API).

Compact simulators offer companies a cost-effective way to develop and manufacture new product formulations. Compaction profile assessments are provided which addresses the variability of a new formulation, offers a greater focus for validation and determination of key tablet properties. Additionally, this technology matches compaction profiles of various tablet machines at different speeds, simulating behavior during large-scale manufacture; thereby providing performance predictions which resolve potential process-related tablet manufacturing issues.

“We are very pleased to partner with PTI Inc. to offer clients access to formulation design and characterization studies which analyze and identify potential performance issues early in the drug formulation process,” said Russell Somma, Ph.D., President. “For our clients to achieve their product goals, rapid commercialization of process into the production environment is mandatory. Together, SommaTech and PTI Inc., deliver affordable, innovative solutions that positively impact the drug development process, ultimately accelerating product entry into the market.”

“How companies leverage new developments can help them break through process barriers to realize substantial competitive advantages,” stated Metin Celik, Ph.D., President, Pharmaceutical Technologies International, Inc. “SommaTech and PTI Inc. bring deep industry experience and technological innovation to help clients reduce the amount of time to reach peak sales.”

About SommaTech
SommaTech, LLC is a pharmaceutical development technology consulting company focused on providing clients with value-added solutions that speed pharma and biopharma products to market as well as helping clients achieve their business goals. SommaTech assists clients with strategic and tactical implementation to bring products to peak sales rapidly and fully realize the potential of the product’s life cycle. Located in Somerset, New Jersey, SommaTech has over 21 successful NDAs and more than 50 product and product assessments. For more information, visit www.sommatechconsulting.com

About PTI Inc.
Pharmaceutical Technologies International, Inc. (PTI Inc.) develops first quality generic and tailored pharmaceutical expert systems, databases and management tools utilized by pharmaceutical scientists in solid dosage formulation and process design. As a companion services to its global formulation and regulatory inspection and development consultation services, PTI Inc. generates state-of-the-art compaction simulation profiles on client's individual raw materials and formulations. For additional information, visit www.pt-int.com.